rss
Thorax 2007;62:757
  • Miscellaneous

What factors are predictive of survival in patients with non-small-cell lung cancer treated with gefitinib?

  1. Kirsten Archer
  1. Specialist Registrar, Basildon Hospital, UK; kirstenarcher@doctors.net.uk

    ▴ Satouchi M, Negoro S, Funada Y, et al. Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib. Br J Cancer2007;96:1191–6.

    This study identified factors associated with prognostic benefit from gefitinib chemotherapy. Japanese patients who had received gefitinib monotherapy between 2002 and 2005 at the Hyogo Medical Centre for Adults in Japan (n = 221) were included in the study. Their clinical parameters were retrospectively …

    [Full text of this article]

    This Article

    1. Extract
    2. Full text
    3. PDF

    Social bookmarking

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
    View free sample issue >>

    Free archive
    The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.